Topical fluticasone propionate lotion does not cause HPA axis suppression.

[1]  M. Schaller,et al.  Safety and Efficacy of Fluticasone Propionate in the Topical Treatment of Skin Diseases , 2004, Skin Pharmacology and Physiology.

[2]  N. Zetola.  Health CareAssociated Bloodstream Infections , 2003 .

[3]  R. Damstra,et al.  Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study , 2003, BMJ : British Medical Journal.

[4]  H. Williams,et al.  The use of corticosteroids and corticosteroid phobia in atopic dermatitis. , 2003, Clinics in dermatology.

[5]  I. van der Waal,et al.  Ano‐genital granulomatosis: the counterpart of oro‐facial granulomatosis 1 , 2003, Journal of the European Academy of Dermatology and Venereology : JEADV.

[6]  J. Hanifin,et al.  Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients , 2002, The British journal of dermatology.

[7]  D. Eedy.  Imiquimod: a potential role in dermatology? , 2002, The British journal of dermatology.

[8]  S. Friedlander,et al.  Safety of fluticasone propionate cream 0.05% for the treatment of severe and extensive atopic dermatitis in children as young as 3 months. , 2002, Journal of the American Academy of Dermatology.

[9]  W. Westerhof,et al.  Left-right comparison study of the combination of fluticasone propionate and UV-A vs. either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo. , 1999, Archives of dermatology.

[10]  A. Wolkerstorfer,et al.  Fluticasone propionate 0.05% cream once daily versus clobetasone butyrate 0.05% cream twice daily in children with atopic dermatitis. , 1998, Journal of the American Academy of Dermatology.

[11]  L. Wiseman,et al.  Topical fluticasone propionate: a review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders. , 1997, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

[12]  J. Barron.  Diagnosis of Adrenal Insufficiency , 1996, Annals of clinical biochemistry.

[13]  A. Chu,et al.  Fluticasone propionate 0.05% cream in the treatment of atopic eczema: a multicentre study comparing once‐daily treatment and once‐daily vehicle cream application versus twice‐daily treatment , 1995, The British journal of dermatology.

[14]  A. Chu,et al.  Fluticasone propionate in the treatment of inflammatory dermatoses. , 1995, The British journal of clinical practice.